Onus IV Review

What Onus IV charges

• NAD+: $60/mo — per shot at the 100 mg dose, with no billing period stated; the members' rate on the same rung is $49, and the published ladder runs 200 mg at $120 ($87.50 for members), 250 mg at $150 ($105), 300 mg at $180 ($122) and 350 mg at $210 ($130) — so the member discount rises from 18 per cent at the smallest dose to 38 per cent at the largest rather than being one percentage
• Glutathione: $40/mo — per shot at what the page calls the 400 mg standard dosage, with no billing period stated; the members' price on the same line is $28
• Sermorelin: $260/mo — the bottom of a published range and not a rate — the peptide menu reads "Price: $260-$400 (depending on dosage / protocol)" and states no period, no strength and no supply length, so this figure is a floor rather than a cost of treatment
• GHK-Cu: $300/mo — a bare figure — the peptide menu reads "GLOW (GHK CU) ... Price: $300" with no quantity, no strength and no period beside it, unlike this seller's NAD+ and glutathione lines, which both state a dose

A ladder priced by dose, with two prices on every rung

The NAD+ page lists five doses, each with its own milligram amount, its own standard price and its own member price. That is a level of detail this category almost never publishes.

The member rate is not one discount applied across the ladder. It is a smaller saving on the smallest dose and a much larger one on the largest, and the gap between the two widens on every rung in between.

So a row carrying a single percentage off would be wrong on four of the five doses. This site records the entry rung as the figure and carries the whole ladder, both columns, in the qualifier beside it.

The glutathione line has the same two-price shape at a single stated dose, and it is the lowest published figure on either of its boards.

Two peptide listings that cannot be reduced to a rate

The peptide menu prices sermorelin as a range, and says the range depends on the dosage and the protocol. It states no strength, no supply length and no period.

GHK-Cu on the same menu is a single bare figure with no quantity, no strength and no period beside it. Twenty-one of the fifty-three sellers here carry GHK-Cu, and this is one of the few that prices it with nothing attached.

The bottom of the sermorelin range is recorded as a floor and labelled as one. Neither of these two can honestly be described as a cost of treatment, and the qualifiers say so.

None of the figures on this seller states a billing period. They are per shot or per protocol, which is what an in-clinic menu prices.

Two weight-loss rows that name no molecule

The same peptide menu carries two weight-loss listings priced as ranges. Neither names a compound: one is titled as a class of peptide and the other as a pairing of two classes.

This site does not read a molecule into either. Naming a specific weight-loss compound here would be an inference dressed up as a reading, and this roster records what a page says rather than what a category implies.

So neither weight-loss compound is declared on this row, and neither range is recorded as a price.

That is a deliberate absence rather than an oversight, and it is why the compound list on this row is shorter than the menu looks.

One state, no terms of service, and an address missing its city

Coverage is a single state, published as a list of clinic locations plus a mobile service, and the NAD+ page's own title names that state. Twenty-four of the fifty-three sellers compared here publish a state footprint of any kind, and one state is the narrowest of the twenty-four.

This is an in-clinic and mobile chain rather than a national mail-order seller, which is the first thing a reader of a national comparison needs to know about it.

There is no terms-of-service page on the site at all. The published documents are a privacy policy and a disclaimer, and neither names a governing law, so no forum is identifiable in advance.

The address in the privacy policy gives a street, a state and a postal code and omits the city. This site records what is published rather than filling the city in, and eleven of the fifty-three sellers here name the facility that fills an order, which this one does not.

How we verified this

• Read the NAD+ and glutathione menu pages and the peptide menu as rendered text in a browser, with the pages' own toggles opened.
• Recorded that the ladder rows have no laid-out box until a toggle is clicked, and the text length before and after opening it, so the difference is on the record.
• Copied both columns of the ladder rung by rung and computed the member saving on each rung separately, which is how the widening discount was found.
• Declined to write a single percentage anywhere, because no single percentage is true across the ladder.
• Recorded the sermorelin listing as a range with its floor named as a floor, and the GHK-Cu listing as a bare figure, rather than treating either as a rate.
• Read the two weight-loss listings and confirmed neither names a molecule, then declined to declare either compound on this row.
• Read the privacy policy and the disclaimer for an operating company, an address and a governing law, and confirmed no terms-of-service page exists in the site's own link list.
• Recorded that the published address omits the city rather than supplying the city its postal code suggests.
• Confirmed the host answers a nonsense path with a not-found status at two path depths in the same pass, and noted its not-found page carries an empty title, so a title match cannot be used as a check here.
• Searched the published federal warning-letter record for the company name and found no letter to it. That record does not include untitled letters.
• Re-counted the state-footprint, GHK-Cu and pharmacy-naming claims against the current roster, and re-derived the narrowest-footprint ordinal, which this row changed.